171 related articles for article (PubMed ID: 2581010)
21. Deferoxamine-induced bone changes in haemodialysis patients: a histomorphometric study.
Charhon SA; Chavassieux P; Boivin G; Parisien M; Chapuy MC; Traeger J; Meunier PJ
Clin Sci (Lond); 1987 Aug; 73(2):227-34. PubMed ID: 3652627
[TBL] [Abstract][Full Text] [Related]
22. [Total parathyroidectomy in treatment of Sagliker syndrome in 10 cases of hemodialysing patients with secondary hyperparathyroidism].
Zhang L; Yao L; Hua Z; Bian WJ; Li WG
Zhonghua Nei Ke Za Zhi; 2011 Jul; 50(7):562-7. PubMed ID: 22041265
[TBL] [Abstract][Full Text] [Related]
23. Changes of bone remodeling immediately after parathyroidectomy for secondary hyperparathyroidism.
Yajima A; Ogawa Y; Takahashi HE; Tominaga Y; Inou T; Otsubo O
Am J Kidney Dis; 2003 Oct; 42(4):729-38. PubMed ID: 14520623
[TBL] [Abstract][Full Text] [Related]
24. Bone turnover markers predict changes in bone mineral density after parathyroidectomy in patients with renal hyperparathyroidism.
Lu KC; Ma WY; Yu JC; Wu CC; Chu P
Clin Endocrinol (Oxf); 2012 May; 76(5):634-42. PubMed ID: 22007930
[TBL] [Abstract][Full Text] [Related]
25. Long-term outcomes and management considerations after parathyroidectomy in the dialysis patient.
Kakani E; Sloan D; Sawaya BP; El-Husseini A; Malluche HH; Rao M
Semin Dial; 2019 Nov; 32(6):541-552. PubMed ID: 31313380
[TBL] [Abstract][Full Text] [Related]
26. Surgical indications and procedures of parathyroidectomy in patients with chronic kidney disease.
Tominaga Y; Matsuoka S; Sato T
Ther Apher Dial; 2005 Feb; 9(1):44-7. PubMed ID: 15828905
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness of surgical parathyroidectomy for secondary hyperparathyroidism in renal dialysis patients in Qatar.
Rashed A; Fahmi M; ElSayed M; Aboud O; Asim M
Transplant Proc; 2004; 36(6):1815-7. PubMed ID: 15350484
[TBL] [Abstract][Full Text] [Related]
28. Kinetics of parathyroid hormone after parathyroidectomy in chronic hemodialysis patients.
Skalli Z; Elouazzani H; Alhamany Z; Mattous M; Benamar L; Bayahia R; Belkouchi M; El Malki H; Ouzeddoun N
Saudi J Kidney Dis Transpl; 2015 Nov; 26(6):1199-204. PubMed ID: 26586059
[TBL] [Abstract][Full Text] [Related]
29. Parathyroidectomy in chronic renal failure.
de Francisco AM; Ellis HA; Owen JP; Cassidy MJ; Farndon JR; Ward MK; Kerr DN
Q J Med; 1985 Jun; 55(218):289-315. PubMed ID: 4023172
[TBL] [Abstract][Full Text] [Related]
30. Relationship between the weight of parathyroid glands and their secretion of parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism.
Kakuta T; Tanaka R; Kanai G; Miyamoto Y; Inagaki M; Suzuki H; Fukagawa M; Saito A
Ther Apher Dial; 2008 Oct; 12(5):385-90. PubMed ID: 18937722
[TBL] [Abstract][Full Text] [Related]
31. Chronic renal failure: diagnostic measures before parathyroidectomy.
Dahl E; Nordal KP; Halse J
Scand J Urol Nephrol; 1994 Sep; 28(3):291-4. PubMed ID: 7817173
[TBL] [Abstract][Full Text] [Related]
32. Elective total parathyroidectomy without autotransplant in end-stage renal disease.
Kaye M; D'Amour P; Henderson J
Kidney Int; 1989 Jun; 35(6):1390-9. PubMed ID: 2770117
[TBL] [Abstract][Full Text] [Related]
33. The high prevalence of alexithymia in hemodialyzed patients with secondary hyperparathyroidism unsuppressed by medical therapy is cured by parathyroidectomy.
De Santo RM; Livrea A; De Santo NG; Conzo G; Bilancio G; Celsi S; Cirillo M
J Ren Nutr; 2010 Sep; 20(5 Suppl):S64-70. PubMed ID: 20797574
[TBL] [Abstract][Full Text] [Related]
34. Long term results of subtotal parathyroidectomy in patients with end-stage renal disease.
Kim HC; Cheigh JS; David DS; Stubenbord W; Sullivan J; Rubin AL; Stenzel KH
Am Surg; 1994 Sep; 60(9):641-9. PubMed ID: 8060033
[TBL] [Abstract][Full Text] [Related]
35. Aluminum localization in bone from hemodialyzed patients: relationship to matrix mineralization.
Cournot-Witmer G; Zingraff J; Plachot JJ; Escaig F; Lefèvre R; Boumati P; Bourdeau A; Garabédian M; Galle P; Bourdon R; Drüeke T; Balsan S
Kidney Int; 1981 Sep; 20(3):375-8. PubMed ID: 7300127
[TBL] [Abstract][Full Text] [Related]
36. Osteomalacia after parathyroidectomy in patients with uremia.
Felsenfeld AJ; Harrelson JM; Gutman RA; Wells SA; Drezner MK
Ann Intern Med; 1982 Jan; 96(1):34-9. PubMed ID: 7053699
[TBL] [Abstract][Full Text] [Related]
37. Hyperparathyroidism: a seven-year follow-up.
Juergensen PH; Cooper K; Kliger AS; Finkelstein FO
Adv Perit Dial; 1998; 14():188-90. PubMed ID: 10649721
[TBL] [Abstract][Full Text] [Related]
38. Procollagen type 1 C-terminal extension peptide serum levels following parathyroidectomy in hyperparathyroid patients.
Coen G; Mazzaferro S; De Antoni E; Chicca S; DiSanza P; Onorato L; Spurio A; Sardella D; Trombetta M; Manni M
Am J Nephrol; 1994; 14(2):106-12. PubMed ID: 8080002
[TBL] [Abstract][Full Text] [Related]
39. Type of subtotal parathyroidectomy and evolution of parathyroid hormone levels in end-stage renal disease patients: a retrospective cohort study.
Wang YP; Sidibé A; Roussy LO; Desbiens LC; Gilbert A; Mac-Way F
Int Urol Nephrol; 2020 Nov; 52(11):2171-2178. PubMed ID: 32725511
[TBL] [Abstract][Full Text] [Related]
40. Intra-operative parathyroid hormone monitoring through central laboratory is accurate in renal secondary hyperparathyroidism.
Vulpio C; Bossola M; Di Stasio E; Pepe G; Nure E; Magalini S; Agnes S
Clin Biochem; 2016 May; 49(7-8):538-43. PubMed ID: 26800781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
